Skip to main content

Mucus Relief DM

NDC 0363-0533 · Walgreen Company

Generic nameDextromethorphan HBr, Guaifenesin
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Strength20; 400 mg/1; mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

0363-0533-01 — 1 BOTTLE, PLASTIC in 1 CARTON (0363-0533-01) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

0363-0533-32 — 2 BOTTLE, PLASTIC in 1 CARTON (0363-0533-32) / 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0363-0337 — dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 0363-0384 — dextromethorphan polistirex, 0363-0401 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 0363-0437 — Guaifenesin, Dextromethorphan HBr, 0363-0474 — Guaifenesin and Dextromethorphan HBr, 0363-0494 — dextromethorphan polistirex, 0363-0506 — Dextromethorphan HBr, Guaifenesin, 0363-0510 — Guaifenesin and Dextromethorphan HBr, 0363-0512 — Dextromethorphan HBr, Guaifensin, Phenylephrine HCI, 0363-0532 — Guaifenesin, 0363-0542 — Guaifenesin, Phenylephrine HCl, 0363-0566 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 0363-0570 — Guaifenesin, 0363-0603 — acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl, 0363-0623 — Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl, 0363-0640 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-0666 — acetaminophen, dextromethorphan Hbr, Phenylephrine HCl, 0363-0681 — dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 0363-0733 — Guaifenesin, Dextromethorphan HBr, 0363-0758 — Dextromethorphan HBr, Doxylamine succinate, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels